Danni Supplee

Title: Danni Supplee: Innovator in Controlled Release Drug Delivery

Introduction

Danni Supplee is a notable inventor based in Bend, Oregon. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. Her work focuses on enhancing the efficacy and safety of medication through controlled release mechanisms.

Latest Patents

Danni Supplee holds a patent for a hydrogel-driven layered drug dosage form. This controlled release dosage form for sertraline features a core that comprises a sertraline-containing composition and a water-swellable composition. The water-swellable composition is strategically placed in a separate region within the core. The dosage form is designed with a coating that is water-permeable and water-insoluble, featuring at least one delivery port. This innovative design allows for a controlled release of sertraline, with specific release rates defined for various time intervals.

Career Highlights

Danni is currently employed at Pfizer Corporation, where she continues to advance her research in drug delivery systems. Her work has the potential to improve patient outcomes by providing more effective medication regimens. With a focus on innovation, she has successfully developed a dosage form that releases sertraline at an average rate of 6 to 10 wt % per hour after introduction to a use environment.

Collaborations

Danni has collaborated with esteemed colleagues such as William John Curatolo and Kenneth C Waterman. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceuticals.

Conclusion

Danni Supplee's contributions to the pharmaceutical industry exemplify the importance of innovation in drug delivery systems. Her patented hydrogel-driven dosage form represents a significant advancement in controlled release technology, showcasing her dedication to improving healthcare solutions.